Analysis of immune-metabolic targets, material design strategies, and translational hurdles shaping next-generation osteoarthritis clinical therapeutics.
Key Takeaways
- Is a degenerative joint disease characterized by immune-metabolic dysregulation
- Basic treatment is indicated for patients with mild OA symptoms
- Prolonged NSAID use is associated with risks of gastrointestinal mucosal injury